Trav3d-2 Activators
TRAV3D-2 Activators are a class of chemical agents that engage with and activate T-cell receptor (TCR) associated pathways, potentially leading to the activation of TCRs that include the TRAV3D-2 chain. These activators operate by modulating various biological signaling mechanisms that are integral to T-cell activation and function. For instance, some activators in this class target kinases that are directly involved in TCR signaling, such as protein kinase C (PKC) and ZAP70. PKC plays a pivotal role in TCR-mediated signaling cascades, influencing the transcription and subsequent immune response. Inhibition or activation of PKC can lead to changes in TCR signaling dynamics. Similarly, ZAP70 is a tyrosine kinase that, upon engagement, phosphorylates multiple substrates leading to the amplification of the TCR signal.
Additionally, other molecules within the TRAV3D-2 Activators class focus on manipulating calcium levels within T-cells, which is a crucial second messenger in TCR signal transduction. Calcium ionophores, for example, elevate intracellular calcium concentrations, mimicking TCR engagement signals and potentially initiating the activation cascade associated with TRAV3D-2 containing TCRs. Another target within this chemical class is the mTOR pathway, which is essential for T-cell metabolism and function. Modulation of this pathway can lead to alterations in T-cell activation. Moreover, the MAPK/ERK pathway, which is involved in cell proliferation and differentiation, can also be influenced by these activators. Inhibitors of certain kinases in this pathway can lead to variations in TCR signaling, which may affect the activation state of TRAV3D-2. Through these diverse mechanisms, TRAV3D-2 Activators engage with the complex network of T-cell signaling, each influencing the TCR in a distinctive manner, thereby contributing to the modulation of the immune response.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in TCR signaling. PKC activation can lead to enhanced TCR-mediated signaling pathways, which could possibly activate TCRs that include TRAV3D-2. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, simulating the signal transduction event of TCR engagement, which could possibly activate TCRs expressing TRAV3D-2. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin, which normally dephosphorylates NFAT following TCR engagement. Modulation of this pathway by cyclosporin A could possibly activate TCR signaling pathways, affecting TCRs with TRAV3D-2. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK, a kinase in the MAPK/ERK pathway. By modulating this pathway, U0126 could possibly activate TCR signaling and affect the activity of TCRs including TRAV3D-2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase that is a crucial regulator of T cell metabolism and function. mTOR inhibition could possibly activate TCR signaling and thereby influence the function of TCRs with TRAV3D-2. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor that can affect multiple kinases involved in TCR signaling, which could possibly activate the activity of TCRs with TRAV3D-2. | ||||||
PP 1 | 172889-26-8 | sc-203212 sc-203212A | 1 mg 5 mg | $86.00 $145.00 | 6 | |
PP2 is an Src family kinase inhibitor that could affect Lck and Fyn, which are critical for initiating TCR signaling, and thereby could possibly activate TCRs with TRAV3D-2. | ||||||
Rottlerin | 82-08-6 | sc-3550 sc-3550B sc-3550A sc-3550C sc-3550D sc-3550E | 10 mg 25 mg 50 mg 1 g 5 g 20 g | $84.00 $166.00 $302.00 $2091.00 $5212.00 $16657.00 | 51 | |
Rottlerin is often used as a PKC inhibitor, although it has multiple other targets. It could possibly activate TCR signaling pathways, influencing TCRs including TRAV3D-2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that disrupts calcium homeostasis in cells. By affecting calcium signaling, it could possibly activate the activation of TCRs with TRAV3D-2. | ||||||
CRAC Channel Inhibitor, BTP2 | 223499-30-7 | sc-221441 | 5 mg | $189.00 | 9 | |
BTP2 is an inhibitor of calcium release-activated calcium (CRAC) channels. By modulating calcium influx, it could possibly activate TCR signaling and influence the activity of TCRs including TRAV3D-2. | ||||||